ATYR
aTyr Pharma
ATYR
ATYR
36 hedge funds and large institutions have $39.8M invested in aTyr Pharma in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.31% less ownership
Funds ownership: 66.57% → 63.27% (-3.3%)
30% less capital invested
Capital invested by funds: $57.2M → $39.8M (-$17.4M)
80% less call options, than puts
Call options by funds: $18K | Put options by funds: $91K
Holders
36
Holding in Top 10
1
Calls
$18K
Puts
$91K
Top Buyers
| 1 | +$938K | |
| 2 | +$751K | |
| 3 | +$657K | |
| 4 |
TI
Telemetry Investments
New York
|
+$288K |
| 5 |
Millennium Management
New York
|
+$149K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.8M | |
| 3 | -$498K | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$422K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$137K |